Total il-12 levels are increased in paediatric atopic dermatitis: Correlations with age and disease severity

International Journal of Immunopathology and Pharmacology

Volumn 21, Issue 2, 2008, Pages 359-365

  Piancatelli, Daniela ^a,d   Bellotta, L ^b   Del Beato, T ^a   Duse, M ^c   Della Penna, M R ^b  

^a CNR Institute for Organ Transplantation and Immunocytology   (Italy)

^b SAN SALVATORE HOSPITAL   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

^d CNR Istituto Per I Trapianti d'Organo e l'Immunocitologia   (Italy)

Author keywords

Atopic dermatitis; Interleukin 12; Th1 Th2

Indexed keywords

CD30 ANTIGEN; CYTOKINE; INTERLEUKIN 12; INTERLEUKIN 12P40; INTERLEUKIN 12P70;

AGE; ARTICLE; ATOPIC DERMATITIS; BLOOD LEVEL; CHILD; CYTOKINE PRODUCTION; DISEASE COURSE; DISEASE SEVERITY; FAMILY HISTORY; FEMALE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOMODULATION; INFANT; MALE; OUTCOME ASSESSMENT; PATHOGENESIS; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; TH1 CELL; TH2 CELL;

EID: 47249139496     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/039463200802100213     Document Type: Article

References (24)

1. Coleman R, Trembath RC, Harper JI. Genetic studies of atopy and atopic dermatitis. Brit J Dermatol 1997; 136:1-5.
2. Leung DY, Bieber T. Atopic dermatitis. Lancet 2003; 361:151-60.
3. Leung DYM, Boguniewicz M, Howell MD, Nomura I, Hamid QA. New insights into atopic dermatitis. J Clin Invest 2004; 113:651-7.
4. Spergel JM, Paller AS. Atopic dermatitis and the atopic march. J Allergy Clin Immunol 2003; 112:S118-27.
5. Novak N, Bieber T. Allergic and non-allergic forms of atopic diseases. J Allergy Clin Immunol 2003; 112:252-62.
6. Boguniewicz M, Leung YM. Atopic dermatitis. J Allergy Clin Immunol 2006; 117:S475-80.
7. Lester MR, Hofer MF, Gately M, Trumble A, Leung DYM. Down-regulating effects of IL-4 and IL-10 on the IFN- response in atopic dermatitis. J Immunol 1995; 154:6174-81.
8. Del Prete G, De Carli M, Almerignola F, Daniel CK, D'Elios MM, Zancuoghi G, Vinante F, Pizzolo G, Romagnani S. Preferential expression of CD30 by human CD4+ T cells producing Th2-type cytokines. FASEB J 1995; 9:81-6.
9. Romagnani S, Del Prete G, Maggi E, Chiosi M, Caligaris-Cappio F, Pizzolo G. CD30 and type 2 T helper (Th2) responses. J Leuk Biol 1995; 57:726-30.
10. Bengtsson A, Holm L, Back O, Fransson J, Scheynius A. Elevated serum levels of soluble CD30 in patients with atopic dermatitis (AD). Clin Exp Immunol 1997; 109:533-7.
11. Oppmann B, Lesley R, Blom B et al. Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity 2000; 5:715-25.
12. Anderson EJR, McGrath MA, Thalhamer T, McInnes IB. Interleukin-12 to interleukin 'infinity': the rationale for future therapeutic cytokine targeting. Springer Semin Immun 2006; 27:425-42.
13. Hanifin JM, Rajka G. Diagnostic features of atopic dermatitis. Acta Derm Venereol (Stockh) 1980; 92(S):44-7.
14. The European Task Force on Atopic Dermatitis. Severity scoring of atopic dermatitis: the SCORAD index. Consensus report of the European task force on atopic dermatitis. Dermatology 1993; 186:21-31.
15. Caproni M, Bianchi B, D'Elios MM, De Carli M, Amedei A, Fabbri P. In vivo relevance of CD30 in atopic dermatitis. Allergy 1997; 52:1063-70.
16. Jung T, Moessner R, Dieckhoff K, Heidrich S, Neumann C. Mechanisms of deficient interferon-gamma production in atopic diseases. Clin Exp Allergy 1999; 29:912-9.
17. Watford WT, Moriguchi M, Morinobu A, O'Shea JJ. The biology of IL-12: coordinating innate and adaptive immune response. Cytokine Growth Factors Rev 2003; 14:361-8.
18. Rea IM, McNerlan SE, Alexander HD. Total serum IL-12 and IL-12 p40, but not IL-12 p70, are increased in the serum of older subjects; relationship to CD3+ and NK subsets. Cytokine 2000; 12:156-9.
19. Abdi K. IL-12: the role of p40 versus p75. Scand J Immunol 2002; 56:1-11.
20. Dudley DJ, Hunter C, Mitchell MD, Varner MW, Gately M. Elevations of serum interleukin-12 concentrations in women with severe pre-eclampsia and HELLP syndrome. J Reprod Immunol 1996; 31:97-107.
21. Prescott SLTJ, Taylor A, King B, Dunstan J, Upham JW, Thornton CA, Holt PG. Neonatal interleukin-12 capacity is associated with variations in allergen-specific immune responses in the neonatal and postnatal periods. Clin Exp Allergy 2003; 33:566-72.
22. Itazawa T, Adachi Y, Okabe Y, Hamamichi M, Adachi YS, Toyoda M, Morohashi M, Miyawaki T. Developmental changes in interleukin-12-producing ability by monocytes and their relevance to allergic diseases. Clin Exp Allergy 2003; 33:525-30.
23. Holt PG, Macaubas C. Development of long-term tolerance versus sensitisation to environmental allergens during the perinatal period. Curr Opin Immunol1997; 9:782-7.
24. Blanco Quiros A, Arranz E, Hoyos C, Carrasco JA, Andion R. Different serum interleukin-12 and sCD30 levels in food- and pollen-sensitized children. Pediatr Allergy Immunol 1999; 10:235-40.